Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Humatica, the leading specialist advisor to private equity firms on organizational effectiveness, is proud to announce that it has been named Value Creation Adviser of…
Read moreHumatica, the specialist advisor to private equity firms on organizational effectiveness, has been awarded Actum’s Value Creation Award in the People & Organizational Strategy category—for…
Read moreHumatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…
Read more